| 3D | three-dimensional |
| 5-FU | 5-fluorouracil |
| AAP | Auricularia auricula polysaccharides |
| ADC | antibody-drug conjugate |
| ADEPT | antibody-directed prodrug therapy |
| ADH | adipohydrazide |
| CDDP | cis-diamminedichloroplatinum (II) |
| CTR | centyrin |
| CTS | chitosan |
| CTS-NPs | Hase-chitosan NPs |
| CHS | cholesterol |
| CM-PL | carboxymethyl pullulan |
| DA | deoxycholic acid |
| DEX | Dextran |
| DOX | doxorubicin |
| DS | dextran-spermine |
| DSPIONs | dextran-coated superparamagnetic iron oxide NPs |
| DTX | docetaxel |
| EPR | enhanced permeability and retention |
| FA | folic acid |
| FGFR1 | fibroblast growth factor receptors |
| FR | folate receptor |
| GDEPT | gene-directed enzyme prodrug |
| GEM | gemcitabine |
| Gly | glycine |
| HA | hyaluronic acid |
| Hase | hyaluronidase |
| HEP | heparinHis histidine |
| HPMA | 2-hydroxypropyl methacrylate |
| IC50 | half-maximal inhibitory concentration |
| Ile | isoleucine |
| KIT | tyrosine-protein kinase |
| Leu | leucine |
| LPNPs | lipid-polymer hybrid nanoparticles |
| LYVE-1 | lymphatic vessel endothelium receptor-1 |
| MMP-2 | matrix-metalloproteinase-2 |
| MMP-9 | matrix-metalloproteinase-9 |
| MTX | methotrexate |
| MYD88 | myeloid differentiation factor 88 |
| NP(s) | nanoparticle(s) |
| oDex | oxidized dextran |
| PDC | polymer–drug conjugates |
| PDEPT | polymer-directed enzyme prodrug therapy |
| PDGFR1 | platelet-derived growth factor receptors |
| PDTC | pyrrolidine dithiocarbamate |
| PeDC | Peptide–drug conjugate |
| PELT | polymer enzyme liposome therapy |
| PFEP | poly{[9,9-bis(6′-(N,N,N-diethylmethylammonium)hexyl) 2,7-fluorenylene ethynylene]-alt-co-[2,5-bis(3′-(N,N,N-diethylmethylammonium)-1′-oxapropyl)-1,4-phenylene]} tetraiodide |
| Phe | phenylalanine |
| PL | pullulan |
| PLA | pullulan acetate |
| PrDC | protein-drug conjugate |
| Pro | proline |
| PTX | paclitaxel |
| RHAMM | receptor for hyaluronan-mediated motility |
| S | sorafenib |
| SELP | silk-elastin-like polymer |
| SF | silk fibroin |
| TiO2 NPs | titanium dioxide nanoparticles |
| TLR4 | toll-like receptor 4) |
| Val | valine |
| VDEPT | virus-directed enzyme prodrug therapy |
| VEGFR | vascular endothelial growth factor |